Cytek Biosciences (NASDAQ:CTKB – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it contrast to its competitors? We will compare Cytek Biosciences to related businesses based on the strength of its valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and earnings. Institutional & Insider Ownership 36.0% of […]